摘要:加拿大McGill大学健康中心的James M.Brophy博士及其同事在2月的《心脏》(Heart2007;93:189—194.)杂志上报告。如果有心肌梗死病史的患者使用罗非考昔或塞来考昔这两种COX-2选择性抑制剂之一,则再次发生心肌梗死的风险增加。
注:因版权方要求,不能公开全文,如需全文,请咨询杂志社
热门期刊服务
Acta Pharmacologica Sinica Journal of Semiconductors Journal of Genetics and Genomics Communications in Theoretical Physics Hepatobiliary Pancreatic Diseases International Journal of Systems Engineering and Electronics China World Economy Hepatobiliary Pancreatic Diseases International Chinese Optics Letters Applied Geophysics Acta Geologica Sinica Acta Oceanologica Sinica